Heidi Zafra

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

Renaud Louis, Tim Harrison, Pascal Chanez et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 19 citations · Full text

Hereditary Angioedema: A Review.

Heidi Zafra · PubMed · 2022 · 13 citations

Vascular Disease, Immunology, Vascular Malformation +16

Absence of Peripheral Eosinophilia on Initial Clinical Presentation Does Not Rule Out the Diagnosis of Acute Eosinophilic Pneumonia

Becky Buelow, Brian T. Kelly, Heidi Zafra et al. · The Journal of Allergy and Clinical Immunology In Practice · 2015 · 10 citations

Peripheral Eosinophilia, Diagnosis, Respiratory Infection +2